Related Experiment Video
Updated: Sep 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Myocardial diseases in Thai children
Jarupim Soongswang1, Chaisit Sangtawesin, Rekwan Sittiwangkul
1Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Insights
Pediatric myocardial diseases are uncommon but serious, with high mortality rates in dilated cardiomyopathy and restrictive cardiomyopathy. Acute myocarditis outcomes depend on ICU admission and ejection fraction, not IVIG treatment.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Diseases
- Pediatric Critical Care
Background:
- Myocardial diseases represent a significant cause of mortality and morbidity in pediatric populations.
- Understanding outcomes and management strategies for pediatric myocardial diseases is crucial.
Purpose of the Study:
- To investigate the outcomes, prognostic factors, and management of primary myocardial diseases in children.
- To analyze the incidence and characteristics of various pediatric cardiomyopathies.
Main Methods:
- Retrospective study of 209 pediatric patients diagnosed with primary myocardial diseases from 1996-2000 across six Thai university hospitals.
- Analysis included patient demographics, disease types (dilated cardiomyopathy, acute myocarditis, hypertrophic cardiomyopathy, etc.), presenting symptoms, ejection fraction, cardiac troponin T levels, and mortality rates.
Main Results:
- Dilated cardiomyopathy (45%) and acute myocarditis (27.3%) were the most common types. Congestive heart failure was the primary symptom (75%).
- Acute myocarditis showed higher ejection fraction and lower serum cardiac troponin T compared to dilated cardiomyopathy.
- One-year mortality rates varied significantly by disease type, with restrictive cardiomyopathy having the highest (33.3%) and hypertrophic cardiomyopathy the lowest (5.4%).
Conclusions:
- Primary myocardial diseases in children are rare, often presenting with compromised cardiovascular function.
- For acute myocarditis, intensive care unit admission and low ejection fraction at presentation were mortality predictors, whereas IVIG and cTnT levels were not.
- High mortality rates were observed across all groups during the subacute follow-up period.
Unlabelled:
Myocardial diseases are among the important causes of mortality and morbidity in children. This drew the authors attention to the study of myocardial diseases in children to find out the outcome, factors affecting the outcome, and management strategies. The authors retrospectively studied children who had been diagnosed with primary myocardial diseases at six university hospitals in Thailand from January 1996 to December 2000. The total number of cases was 209 which accounted for 1.2 per cent of cardiovascular diseases in children. The patients' ages ranged from 0.1-15 years. These myocardial diseases included dilated cardiomyopathy (DCM) 45 per cent, acute myocarditis 27.3 per cent, hypertrophic cardiomyopathy (HCM) 18.2 per cent, hypertrophic obstructive cardiomyopathy (HOCM) 8.1 per cent and restrictive cardiomyopathy (RCM) 1.4 per cent. Fifty-six per cent of the patients were female. Congestive heart failure was the most common presenting symptom (75%). Median ejection fraction (EF) of acute myocarditis was 42 per cent (15-79%) which was significantly higher than DCM (33.5%, 10-57%). Serum cardiac troponin T (cTnT) was also significantly higher in acute myocarditis than in DCM (0.08 ng/ml, 0.01-0.16 vs 0.01 ng/ml, 0.01-0.10). Within the follow-up period of 1 year (0.1-5.5 years), the mortality rates were 18.8 per cent, 17.0 per cent, 5.4 per cent and 33.3 per cent in DCM, acute myocarditis, HCM and RCM respectively. Factors associated with the mortality rate in acute myocarditis were admission to ICU and low left ventricular EF at presentation while IVIG administration and cTnT level did not.
Conclusion:
Primary myocardial diseases are uncommon. Most of the patients had compromised cardiovascular reserve. Admission to ICU and low EF were factors that affected the mortality in acute myocarditis while intravenous immunoglobulin administration did not. Mortality rate in the subacute follow-up period was high in all groups.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy